This is a U.S. news story, published by Yahoo, that relates primarily to Federal Trade Commission news.
For more U.S. news, you can click here:
more U.S. newsFor more health policy news, you can click here:
more health policy newsFor more news from Yahoo, you can click here:
more news from YahooOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about health policy, you might also like this article about
high prescription drug prices. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest cost medications news, major pharmacy middlemen groups news, news about health policy, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
prescription drug pricesNBC News
•80% Informative
House committee hears testimony from three pharmacy benefit managers.
Federal Trade Commission released a scathing report last month accusing the groups of racking up massive profits by steering patients and employers toward higher-priced drugs.
Three PBMs make up about 80% of the U.S. market, giving them enormous influence over what drugs patients can get covered.
VR Score
81
Informative language
79
Neutral language
57
Article tone
semi-formal
Language
English
Language complexity
50
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
8
Source diversity
3
Affiliate links
no affiliate links